Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of OLMesartan and Calcium Channel Blocker or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)

NCT00454662 is registered in ClinicalTrials.gov with COLM Study Research Organization as lead sponsor.

NCT NCT00454662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00454662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of OLMesartan and Calcium Channel Blocker or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)
Lead sponsor
COLM Study Research Organization
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2007
Completion date
September 30, 2011
Enrollment
5,141 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, diabetes, hypertension